NCT03899077 2024-02-07
SAVE
Cancer Research Antwerp
Phase 2 Unknown
Clinical Trials
12 trialsNCT04356430 2022-12-16
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT05212857 2022-03-16
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Fudan University
Phase 2 Unknown
NCT02917005 2021-07-28
FATIMA
Africa Middle East Cancer Intergroup
Phase 2 Unknown
NCT04736108 2021-02-08
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
West China Hospital
Phase 2 Unknown
NCT02742675 2020-07-07
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
Fudan University
Phase 2 Unknown
NCT03444025 2018-02-23
NeoGONT
Kasr El Aini Hospital
Phase 2 Unknown
NCT01266213 2017-05-01
FLAG
Samsung Medical Center
Phase 2 Unknown
NCT02313051 2014-12-09
MIRACLE
ChineseAMS
Phase 2 Unknown
NCT02072512 2014-02-26
PROOF
Hospital Affiliated to Military Medical Science, Beijing
Phase 2 Unknown
NCT00348998 2013-11-06
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00398489 2010-11-09
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Unknown